Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bogachek

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Biochemistry. Biokhimiia|July 13, 2010
Characterization of glycoprotein E C-end of West Nile virus and evaluation of its interaction force with alphaVbeta3 integrin as putative cellular receptorM V Bogachek, B N Zaitsev, S K Sekatskii, et al.
Oncotarget|February 1, 2018
Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancerJames P De Andrade, Allison W Lorenzen, Vincent T Wu, et al.
Oncogene|January 29, 2014
TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesisA R Cyr, M V Kulak, J M Park, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Biochemistry. Biokhimiia|July 13, 2010
Characterization of glycoprotein E C-end of West Nile virus and evaluation of its interaction force with alphaVbeta3 integrin as putative cellular receptorM V Bogachek, B N Zaitsev, S K Sekatskii, et al.
Oncotarget|February 1, 2018
Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancerJames P De Andrade, Allison W Lorenzen, Vincent T Wu, et al.
Oncogene|January 29, 2014
TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesisA R Cyr, M V Kulak, J M Park, et al.
Pageof 4